Mutations in CTNNB1, which encodes β-catenin, are commonly observed in both hepatoblastoma and certain medulloblastoma subtypes, particularly those classified as WNT subtypes, highlighting a shared oncogenic mechanism that implicates Wnt signaling in the progression and characteristics of these cancers [7,8]. This evidence concerns the gene CTNNB1 and medulloblastoma.